European Archives - Page 1608 of 1636 - European Medical Journal

Current Controversies in Infective Endocarditis

Infective endocarditis (IE) remains a devastating disease with a high mortality. Its microbiology is changing with increasing incidence of Staphylococcus…

EMJ Cardiology 2014

The field of cardiology is a rapidly growing and developing one. Thanks to the progress which has been made within this area, the burden of…

Zydelig® (idelalisib): The Force to Fight CLL and FL

After the European Commission granted the marketing authorisation for Gilead’s Zydelig® (idelalisib), a first-in-class oral treatment for chronic…

The Role of GPs

Recently, I spoke to a group about the role of the General Practitioner (GP) in the community, about the complexity of the role, and about its challenges…

The Oncotype DX® Test and Precision Oncology: New Data Presented at ESMO Further Demonstrate Genomic Health’s Successful Approach to Understanding Tumour Biology

GENEVA, Switzerland, [September 29, 2014] — In line with this year’s theme for the annual European Society for Medical Oncology (ESMO) Congress…

The EMJ Cow Adventures: ERS 2014 Edition

This year, our EMJ team travelled to Munich to attend and review the 24th Annual Congress of the European Respiratory Society (ERS).

ESMO Announces 15 New Designated Centres of Integrated Oncology and Palliative Care

Lugano, 19 September 2014 – Gaps in palliative care for cancer patients are revealed in new research to be presented later at the ESMO 2014 Congress…

ACCA Congress: Ensuring a Rapid Response to Cardiac Emergencies

Monday 16 September 2014 Sophia Antipolis, France – Acute cardiovascular care is the specialty of cardiology dealing with acute problems in need of…

Review: Genetics of Urolithiasis

Urolithiasis constitutes a worldwide health problem with a frequency of up to 15% in the general population.

Review: Evolution of Minimally Invasive Radical Prostatectomy – A Continuous Development

During the last 15 years, minimally invasive surgery has been introduced gradually in surgical treatment for prostate cancer (CaP).